Clinical Trial Update: Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma

View source ↗

Summary

This clinical trial update investigates whether changes in plasma EBV DNA during chemoradiotherapy correlate with outcomes in nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Nasopharyngeal Carcinoma | Status: UNKNOWN